European Pharmacopoeia test for FMD vaccine: The influence of adjuvant, culture, serotype, valency and method of potency trial on dose response curve

Original language	English
Publication status	Published - 2008
Event	Session of the research group of the European commission for the control of foot-and-mouth disease 2006 - Duration: 16 Oct 2006 → 20 Oct 2006

Conference

Conference	Session of the research group of the European commission for the control of foot-and-mouth disease 2006
Period	16/10/06 → 20/10/06

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 

Projects

• 1 Active

Projects per year

• Vesiculaire ziekten en leukose (WOT-01-002-034, WOT-01-003-011)

  Dekker, A.

  1/01/08 → 31/12/24

  Project: LVVN project

  • Foot and Mouth Disease Virus 100%
  • Mouth 88%
  • Foot 76%
  • Foot-and-Mouth Disease Virus 62%
  • Serotype 56%

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Jamal, S. M., Bouma, A., Chenard, G., & Dekker, A. (2008). European Pharmacopoeia test for FMD vaccine: The influence of adjuvant, culture, serotype, valency and method of potency trial on dose response curve. Paper presented at Session of the research group of the European commission for the control of foot-and-mouth disease 2006.

Jamal, S.M. ; Bouma, A. ; Chenard, G. et al. / European Pharmacopoeia test for FMD vaccine: The influence of adjuvant, culture, serotype, valency and method of potency trial on dose response curve. Paper presented at Session of the research group of the European commission for the control of foot-and-mouth disease 2006.

@conference{61743e0de9874ed9a1cef0a4b26ce599,

title = "European Pharmacopoeia test for FMD vaccine: The influence of adjuvant, culture, serotype, valency and method of potency trial on dose response curve",

author = "S.M. Jamal and A. Bouma and G. Chenard and A. Dekker",

year = "2008",

language = "English",

note = "Session of the research group of the European commission for the control of foot-and-mouth disease 2006 ; Conference date: 16-10-2006 Through 20-10-2006",

}

Jamal, SM, Bouma, A, Chenard, G & Dekker, A 2008, 'European Pharmacopoeia test for FMD vaccine: The influence of adjuvant, culture, serotype, valency and method of potency trial on dose response curve', Paper presented at Session of the research group of the European commission for the control of foot-and-mouth disease 2006, 16/10/06 - 20/10/06.

European Pharmacopoeia test for FMD vaccine: The influence of adjuvant, culture, serotype, valency and method of potency trial on dose response curve. / Jamal, S.M.; Bouma, A.; Chenard, G. et al.
2008. Paper presented at Session of the research group of the European commission for the control of foot-and-mouth disease 2006.

Research output: Contribution to conference › Conference paper › Academic

TY - CONF

T1 - European Pharmacopoeia test for FMD vaccine: The influence of adjuvant, culture, serotype, valency and method of potency trial on dose response curve

AU - Jamal, S.M.

AU - Bouma, A.

AU - Chenard, G.

AU - Dekker, A.

PY - 2008

Y1 - 2008

M3 - Conference paper

T2 - Session of the research group of the European commission for the control of foot-and-mouth disease 2006

Y2 - 16 October 2006 through 20 October 2006

ER -

Jamal SM, Bouma A, Chenard G, Dekker A. European Pharmacopoeia test for FMD vaccine: The influence of adjuvant, culture, serotype, valency and method of potency trial on dose response curve. 2008. Paper presented at Session of the research group of the European commission for the control of foot-and-mouth disease 2006.